Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDV-2000 Safety and Interaction Study in Healthy Volunteers and Opioid Use Disorder
NCT04976855Phase 1Completed
- Sponsor
- Indivior
- Start
- Aug 2022
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of C4X3256 in opioid use disorder (OUD) (9 arms), sponsored by Indivior. Primary endpoint: Number of Participants With Adverse Events up to 35 days. Started Aug 2022; status: completed.
02
Drugs
C4X3256
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04976855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976855.